drugset / Trial / NCT00121953

Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis

NCT00121953

RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this study is to compare the effect of rosiglitazone versus placebo on soluble proinflammatory markers in peritoneal fluid of women with endometriosis.

Timeline

Start
2005-07
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule 4 mg

Indications